UKTI Logo Sitemap | Help
Text size: a  a  a Home
Global Gateway
About Us
Who We Are Minister for State CEO
How We Help
Businesses Consultants Press Students
Contact Us
Global Offices
Events
Upcoming events Event coverage
Downloads
UKTI publications Information sheets Investor case studies FAQs Facts & stats Maps Partner publications Presentations Press releases Strategic thinking Audio Video
OurWorld  
 
 
My UK
Create email alerts
 
Why the UK?
Key advantages Business factors
UK economy Regulation Tax environment R&D Immigration Finance and incentives Commercial property Skills and employment Importing and exporting Intellectual property
Investment regions
East of England East Midlands London Northern Ireland North East England North West England Scotland South East England South West England Wales West Midlands Yorkshire and the Humber
Forming a company Living & leisure
 
Your business sector
Aerospace Automotive Creative industries Environment & renewable energy Financial services Food & drink ICT
Electronics Software & IT Services Telecommunications
Life sciences
Biotech & Pharma Healthcare & medical
Nanotechnology More sectors
 
UK advisory network
Welcome to the network Get professional advice
Lawyers Accountants Banks Property Touchdown facilities HR & Recruitment Market entry specialists Trade associations Partner organisations Other
Give professional advice
What is the network Join the network Network FAQs
Network news & events
Biotech & Pharma

UK biotechnology & pharmaceuticals opportunities

The UK is one of the world’s most attractive locations for international pharmaceutical and biotechnology operations.

UK companies account for 40 per cent of biotechnology products in the pipeline by European public companies.

Moreover, 45 per cent of new biotechnology drugs in late-stage clinical trials (Phase III) in Europe are from the UK.

The UK is also the world’s number-two pharmaceuticals exporter and, with R&D investment of over £3.3 billion in 2005, it ranks with the USA and Japan as one of the top three centres for pharmaceutical research.

Read our UK biosciences brochure to find out more about key areas of UK bio and pharma research.

Find the top 10 reasons for undertaking clinical research and trials in the UK.

Get information on developing regenerative medicines in the UK.

Or read case studies for international biotech & pharma companies that are already doing business in the UK.

Related articles

image British marine research makes waves

25-Jun-2008 As an island nation surrounded by seas of differing characteristics, the UK is well placed to become a global leader in marine biotechnology and aquaculture study.

image Cancer research network sets new benchmark for clinical trials

02-Aug-2007 We look at how a groundbreaking research network for cancer studies has doubled the number of cancer patients in clinical trials since its inception in 2001 and is continuing to build on this success.

image UK leads the way to new era in genomics

05-Jul-2007 By pooling resources, 50 UK research teams have opened the door to genetic links in seven common diseases, and at the same time uncovered the true potential of the human genome.

image Technology transfer companies open up university research

06-Jun-2007 There is huge commercial potential tied up in the UK’s publicly funded life sciences research. The question is how can investors tap into this resource?

image Gene therapy made a commercial reality

06-Jun-2007 Twenty years after the first gene therapy trial, the UK’s supportive background for high-risk research has allowed two companies to make the breakthrough to commercialisation.

image Amgen’s investment underlines UK pre-eminence in clinical trials

22-May-2007 Why did leading US biotechnology company Amgen make its largest international investment in London? The National Health Service’s (NHS) skills base holds the answer.

image UK consolidates stem cell network

03-May-2007 Progressive legislation gave the UK the lead in stem cell science. How is a manufacturing and clinical infrastructure being developed on these strong foundations?

image UK charity supports international technology transfer

12-Apr-2007 Cancer Research UK is helping US and Australian researchers to commercialise new cancer drugs. Elements of the work will be conducted at the charity’s London laboratory.



Page 1 of: |1 |2 |3 | All Next>

imagePrintable Version
Email this pageEmail this page
imageAdd to My UK

Page 1 of: |1 |2 |3 | All Next>

Last updated:
25-Jun-2008

Business Support

Andres Gopaul

UK Trade & Investment, London

Send an email

Showcasing the UK Biotechnology and Pharmaceutical Industry

The UK is a centre of excellence and expertise for the Biotechnology and Pharmaceuticals sector. View a short video highlighting the UK’s many successes in this field.